Skip to Main Content

Paper Details

Development and Validation of a Prostate Cancer Genomic Signature that Predicts Early ADT Treatment Response Following Radical Prostatectomy.
Clin Cancer Res
22
2018
Author NameAffiliation
Robert Jeffrey KarnesMayo Clinic
Nicholas ErhoGenomeDx Biosciences Inc.
Mohammed AlshalalfaGenomeDx Biosciences Inc.
Bruce J TrockThe James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine
Ashley E RossThe James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine
Jeffrey J TosoianThe James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine
Mandeep TakharGenomeDx Biosciences Inc.
Daniel E SprattUniversity of Michigan ann arbor
Eric A KleinGlickman Urological and Kidney Institute, Cleveland Clinic
Paul L NguyenDana-Farber/Brigham and Women's Cancer Center and Harvard Medical School
Robert B DenSidney Kimmel Medical College, Thomas Jefferson University
Elai DavicioniGenomeDx Biosciences Inc.
Felix Y FengUniversity of California san francisco
Tamara L LotanJohns Hopkins School of Medicine
Edward M SchaefferFeinberg School of Medicine, Northwestern University
  • 1 - 15

Datasets